Search by category:
Tris Pharma Recalls Infants’ Liquid Ibuprofen Referring Higher Levels of Ibuprofen
Business

Tris Pharma Recalls Infants’ Liquid Ibuprofen Referring Higher Levels of Ibuprofen

The manufacturer company, Tris Pharma recall infant ibuprofen sold by several national retailers. Additionally, a recall has been issued for the medicine sold by CVS, Walmart and Family Dollar. According to the recall statement, the trio recalled stocks probably with higher concentrations of ibuprofen and can be dangerous. Additionally, this could cause babies to develop permanent damage to kidneys. Infants may experience severe symptoms like vomiting, nausea, diarrhea, gastrointestinal bleeding. Additionally, the recall highlights that excessive quantity may be more vulnerable to NSAID-linked renal damage. Till date, no such cases are reported on account of the recall.

The over-the-counter medicine and fever-reducing medicine is meant for infants amid ages of 6 months to two years. The medication is also used to relieve pain that is resulting from headaches, muscle pain, and arthritis. However, the product was sold at Walmart under the brand name of Equate with expiry dates 02/19, 04-19, 08/19 and NDC: 49035-125-23. And CVS sold the product beneath the CVS Health brand with expiry dates 08/19 and NDC: 59779-925-23. Lastly, Family Dollar sold the product under the brand Family Wellness having expiry date 08/19 and NDC: 55319-250-23. The company said that the U.S. Food and Drug Administration is aware of the recall.

However, this is not the first recall including infants’ ibuprofen products. Previously, in April, Pfizer, world’s top biopharmaceutical company, also recalled one of its lots. The stock included companies bubble gum flavored Advil medicine. In place of exceeded ibuprofen, the problem was the faulty dosage cups. Moreover, the caps indicated a teaspoon, and the labels directed the dose in milliliters. The company recalled its products citing probability of overdose, like a teaspoon measures about 5ml. Currently, parents who notice any symptoms should see their doctor. The FDA advises parents to submit their experiences to the department through its web portal.

Post Comment